An observational study in Deep Vein Thrombosis, sponsored by Inari Medical. Enrolling by invitation at 15 sites in Japan. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Inari Medical (part of Stryker) · Observational
The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan.
This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.
785 studies on the registry are indexed under Venous Thrombosis; 110 are open to participants now.
This study's planned enrollment of 100 is below the median of 301 across 274 observational studies indexed under Venous Thrombosis.
Browse Venous Thrombosis studies →Inari Medical is the lead sponsor of 14 studies on the registry; 6 are open to participants now.
First submitted after Inari Medical became part of Stryker.
Counted across the registry records on this site, refreshed daily.
All patients with deep vein thrombosis with acute severe symptoms (excluding postthrombotic syndrome) for whom the ClotTriever® Thrombectomy System was used. Patients will be enrolled until at least 100 subjects complete the follow-up period through 6 months.
This is an all-comers survey of all patients treated with ClotTriever® Thrombectomy System in Japan.
All subjects who the survey device entered their vasculature.
Device: ClotTriever® Thrombectomy System
ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.
Rate of Major Adverse Events
Rate of Major Adverse Events \[All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment\].
Time frame: Through 30 days post index procedure.
Technical Success
Thrombus residual volume assessed by the the treating physician using pre- and post-procedure venography to evaluate the success of thrombus removal.
Time frame: During the index procedure
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.